Seeking Alpha

Merck KGaA subsidiary EMD Serono and Pfizer (PFE -0.8%) announce FDA approval for Rebi Rebidose,...

Merck KGaA subsidiary EMD Serono and Pfizer (PFE -0.8%) announce FDA approval for Rebi Rebidose, a single-use auto-injector for the self-administration of Rebif, a treatment multiple sclerosis. PFE says the drug will be available with three different delivery options in the U.S. early this year.
Comments (1)
  • Jay Adler Comment
    , contributor
    Comments (48) | Send Message
     
    Ever since I purchased round lots of PFE and JNJ with dividends I have experienced significant upside potential and enthusiasm for future growth.
    3 Jan 2013, 01:20 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|